DE69827485D1 - VERBINDUNGEN UND VERFAHREN ZUR HEMMUNG VON WECHSELWIRKUNG ZWISCHEN alpha-CATENIN UND beta-CATENIN - Google Patents

VERBINDUNGEN UND VERFAHREN ZUR HEMMUNG VON WECHSELWIRKUNG ZWISCHEN alpha-CATENIN UND beta-CATENIN

Info

Publication number
DE69827485D1
DE69827485D1 DE69827485T DE69827485T DE69827485D1 DE 69827485 D1 DE69827485 D1 DE 69827485D1 DE 69827485 T DE69827485 T DE 69827485T DE 69827485 T DE69827485 T DE 69827485T DE 69827485 D1 DE69827485 D1 DE 69827485D1
Authority
DE
Germany
Prior art keywords
catenin
beta
alpha
compounds
modulating agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69827485T
Other languages
English (en)
Other versions
DE69827485T2 (de
Inventor
Orest W Blaschuk
J Gour
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Publication of DE69827485D1 publication Critical patent/DE69827485D1/de
Application granted granted Critical
Publication of DE69827485T2 publication Critical patent/DE69827485T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69827485T 1997-04-10 1998-04-14 VERBINDUNGEN UND VERFAHREN ZUR HEMMUNG VON WECHSELWIRKUNG ZWISCHEN alpha-CATENIN UND beta-CATENIN Expired - Fee Related DE69827485T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4336197P 1997-04-10 1997-04-10
US43361P 1997-04-10
PCT/CA1998/000322 WO1998045319A2 (en) 1997-04-10 1998-04-14 COMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN α-CATENIN and β-CATENIN

Publications (2)

Publication Number Publication Date
DE69827485D1 true DE69827485D1 (de) 2004-12-16
DE69827485T2 DE69827485T2 (de) 2005-10-27

Family

ID=21926779

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69827485T Expired - Fee Related DE69827485T2 (de) 1997-04-10 1998-04-14 VERBINDUNGEN UND VERFAHREN ZUR HEMMUNG VON WECHSELWIRKUNG ZWISCHEN alpha-CATENIN UND beta-CATENIN

Country Status (8)

Country Link
US (2) US6551994B1 (de)
EP (1) EP0975660B1 (de)
AT (1) ATE282045T1 (de)
AU (1) AU6914798A (de)
CA (1) CA2286291A1 (de)
DE (1) DE69827485T2 (de)
ES (1) ES2232941T3 (de)
WO (1) WO1998045319A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207639B1 (en) 1996-07-12 2001-03-27 Mcgill University Compounds and methods for modulating neurite outgrowth
US6610821B1 (en) * 1996-07-12 2003-08-26 Mcgill University Compounds and methods for modulating endothelial cell adhesion
US6169071B1 (en) * 1996-07-12 2001-01-02 Mcgill University Compounds and methods for modulating cell adhesion
US6346512B1 (en) 1996-07-12 2002-02-12 Mcgill University Compounds and methods for modulating cell adhesion
US6417325B1 (en) 1996-07-12 2002-07-09 Mcgill University Compounds and methods for cancer therapy
US6333307B1 (en) 1996-07-12 2001-12-25 Mcgill University Compounds and method for modulating neurite outgrowth
US6562786B1 (en) 1996-07-12 2003-05-13 Mcgill University Compounds and methods for modulating apoptosis
EP0937103B1 (de) 1996-07-12 2007-11-28 McGILL UNIVERSITY Verbindungen und verfahren zur regulierung der zellanlagerung
US6465427B1 (en) 1996-07-12 2002-10-15 Mcgill University Compounds and methods for modulating cell adhesion
US7122623B2 (en) 1996-07-12 2006-10-17 Adherex Technologies, Inc. Compounds and methods for modulating cell adhesion
US6503881B2 (en) 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US6180604B1 (en) 1996-08-21 2001-01-30 Micrologix Biotech Inc. Compositions and methods for treating infections using analogues of indolicidin
US6551994B1 (en) * 1997-04-10 2003-04-22 Mcgill University Compounds and methods for inhibiting the interaction between α-catenin and β-catenin
US6683048B1 (en) * 1997-04-10 2004-01-27 Mcgill University Compounds and methods for stimulating gene expression and cellular differentiation
US6790829B1 (en) 1997-07-25 2004-09-14 Seatek Marine Biotechnology, Inc. Cyclic decapeptide antibiotics
US6203788B1 (en) 1997-09-29 2001-03-20 Adherex Inc. Compounds and methods for regulating cell adhesion
JP2002505255A (ja) * 1998-02-21 2002-02-19 マックス−デルブルック−セントラム フュール モレクラーレ メディツィン βカテニンに基づくヒトの疾患の治療薬、その製造及び使用
EP1091762A1 (de) 1998-07-02 2001-04-18 Genzyme Corporation Expression von transgenen in polarisierten zellen
US6277824B1 (en) * 1998-07-10 2001-08-21 Adherex Technologies Compounds and methods for modulating adhesion molecule function
AU4206200A (en) 1999-04-05 2000-10-23 Adherex Technologies Inc. Compounds and methods for stimulating beta-catenin mediated gene expression and differentiation
US6303576B1 (en) * 1999-04-21 2001-10-16 Adherex Technologies Inc. Compounds and methods for modulating β-catenin mediated gene expression
WO2001047954A2 (en) * 1999-12-23 2001-07-05 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw NOVEL cDNAs ENCODING CATENIN-BINDING PROTEINS WITH FUNCTION IN SIGNALLING AND/OR GENE REGULATION
WO2001053331A2 (en) 2000-01-24 2001-07-26 Adherex Technologies, Inc. Peptidomimetic modulators of cell adhesion
WO2002004636A1 (en) * 2000-07-12 2002-01-17 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS
US6835536B2 (en) 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
US20080199471A1 (en) * 2002-03-01 2008-08-21 Bernett Matthew J Optimized cd40 antibodies and methods of using the same
CN105777867A (zh) * 2004-05-11 2016-07-20 艾比吉诺米克斯合作公司 诱导t细胞死亡的表位
EP2190868A4 (de) * 2007-07-31 2011-11-23 Cognosci Inc Verfahren zur hemmung von calcineurin mit apoe-analoga
EP2651971A1 (de) 2010-12-14 2013-10-23 The United States of America, as Represented By the Secretery, Department of Health and Human Services Synthetische peptidinhibitoren des wnt-signalwegs
WO2023183940A2 (en) * 2022-03-24 2023-09-28 The Translational Genomics Research Institute Peptide inhibitors targeting the tbl1-beta-catenin complex

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004745A1 (en) 1989-09-27 1991-04-18 Athena Neurosciences, Inc. Compositions for cell adhesion inhibition and methods of use
US5972884A (en) 1991-03-11 1999-10-26 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
US5922855A (en) * 1993-12-17 1999-07-13 Oregon Health Sciences University Mammalian DNA mismatch repair genes MLH1 and PMS1
US5610281A (en) * 1994-05-03 1997-03-11 Brigham & Women's Hospital, Inc. Antibodies for modulating heterotypic E-cadherin interactions with human T lymphocytes
EP0937103B1 (de) 1996-07-12 2007-11-28 McGILL UNIVERSITY Verbindungen und verfahren zur regulierung der zellanlagerung
EP0970120A2 (de) 1997-03-24 2000-01-12 Onyx Pharmaceuticals, Inc. Zusammensetzungen und methoden für die diagnose und behandlung von krankheiten, die auf der interaktion zwischen beta-catenin und einem transkriptionsfaktor beruhen
US6551994B1 (en) 1997-04-10 2003-04-22 Mcgill University Compounds and methods for inhibiting the interaction between α-catenin and β-catenin
US6683048B1 (en) * 1997-04-10 2004-01-27 Mcgill University Compounds and methods for stimulating gene expression and cellular differentiation
US6303576B1 (en) * 1999-04-21 2001-10-16 Adherex Technologies Inc. Compounds and methods for modulating β-catenin mediated gene expression

Also Published As

Publication number Publication date
US6551994B1 (en) 2003-04-22
ES2232941T3 (es) 2005-06-01
WO1998045319A3 (en) 1998-12-17
US20030236186A1 (en) 2003-12-25
EP0975660B1 (de) 2004-11-10
US7063842B2 (en) 2006-06-20
CA2286291A1 (en) 1998-10-15
EP0975660A2 (de) 2000-02-02
DE69827485T2 (de) 2005-10-27
WO1998045319A2 (en) 1998-10-15
AU6914798A (en) 1998-10-30
ATE282045T1 (de) 2004-11-15

Similar Documents

Publication Publication Date Title
DE69827485D1 (de) VERBINDUNGEN UND VERFAHREN ZUR HEMMUNG VON WECHSELWIRKUNG ZWISCHEN alpha-CATENIN UND beta-CATENIN
WO2000002917A3 (en) Compounds and methods for modulating cadherin-mediated functions
WO1999057149A3 (en) Compounds and methods for modulating nonclassical cadherin-mediated functions
ATE473754T1 (de) Verfahren zur manipulation der zelldifferenzierung
DK0724456T3 (da) CD40-Antistoffer
DE69819066D1 (de) Verfahren zur Abdichtung von unterirdischen Lagerstätten
DE69624590T2 (de) Klebhilfsmittel und verfahren zur darstellung von klebhilfsmittel
DE69431797D1 (de) Verfahren und Stoffe zur Modulation der immunsuppressiven Aktivität und Toxitätvon monoklonalen Antikörpern
DE69603838T2 (de) Verfahren zur behandlung von gasen
DE60224275D1 (de) Moleküle und verfahren zur inhibierung der freisetzung von kim-1
DE69317282D1 (de) Anti-Rezeptor Antikörper gegen den Vitamin B12/transcobalamin II Rezeptor
ATE248190T1 (de) Chemoattraktion-auslösender faktor aus lymphozyten und dessen verwendungen
DE68913251D1 (de) Verfahren zur Verringerung der Heterogenität von monoklonalen Antikörpern.
WO2001072956A3 (en) Compounds and methods for modulating desmosomal cadherin-mediated functions
NO964015L (no) Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer
DE59801882D1 (de) Verfahren zur synchronisierten darstellung von netz-inhalten
ATE170631T1 (de) Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase
DE69615843D1 (de) Il-8 antagonisten zur behandlung von asthma
DE3860525D1 (de) Vorrichtung zur erschliessung von muelldeponiegasquellen und zur erkundung und sanierung von altlasten und verunreinigten boeden.
DE69431549T2 (de) Verfahren zur Einebnung von Halbleiterbauflächen und durch dieses Verfahren hergestellte Bauelemente
DE69808961D1 (de) Verfahren zur darstellung von dicyclopentadien-polyetherestern
ES2115750T3 (es) Ensayo de captura de proteinas de union.
DE69617685D1 (de) Zusammensetzung und verfahren zur stabilisierung von radiomarkierten organischen verbindungen
DE69600624D1 (de) Verbessertes verfahren zur reduktiven hydrolise von nitrilen
DE59602269D1 (de) Verfahren zur phosphatierung von metalloberflächen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee